Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Retinoblastoma major review with updates on Middle East management protocols.

Literature DB >> 23960988

Retinoblastoma major review with updates on Middle East management protocols.

Abstract

Many advances in the field of management of retinoblastoma emerged in the past few years. Patterns of presentation of retinoblastoma in the Middle East region differ from Western community. The use of enucleation as a radical method of eradicating advanced disease is not easily accepted by patient's family. We still do see stage E, failed or resistant retinoblastoma and advanced extraocular disease ensues as a result of delayed enucleation decision. In this review, we discuss updates in management of retinoblastoma with its implication on patients in our part of the world. Identifying clinical and high risk characteristics is important prognostically and are discussed for further management of retinoblastoma cases.

Entities: Disease Species

Keywords: Classification; Histopathology; Middle East; Retinoblastoma; Staging

Year: 2012 PMID： 23960988 PMCID： PMC3729874 DOI： 10.1016/j.sjopt.2012.03.002

Source DB: PubMed Journal: Saudi J Ophthalmol ISSN： 1319-4534

79 in total

1. The evaluation and current concept of retinoblastoma therapy.

Authors: A B REESE; R M ELLSWORTH
Journal: Trans Am Acad Ophthalmol Otolaryngol Date: 1963 Mar-Apr

Review 2. Perturbation of cell cycle regulators in human cancer.

Authors: I Palmero; G Peters
Journal: Cancer Surv Date: 1996

3. Histopathologic observations after intra-arterial chemotherapy for retinoblastoma.

Authors: Ralph C Eagle; Carol L Shields; Carlos Bianciotto; Pascal Jabbour; Jerry A Shields
Journal: Arch Ophthalmol Date: 2011-07-11

4. Trilateral retinoblastoma: a meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma.

Authors: T Kivelä
Journal: J Clin Oncol Date: 1999-06 Impact factor: 44.544

5. External beam radiotherapy for retinoblastoma: II. Lens sparing technique.

Authors: N M Toma; J L Hungerford; P N Plowman; J E Kingston; D Doughty
Journal: Br J Ophthalmol Date: 1995-02 Impact factor: 4.638

6. Lifetime risks of common cancers among retinoblastoma survivors.

Authors: Olivia Fletcher; Douglas Easton; Kristin Anderson; Clare Gilham; Marcelle Jay; Julian Peto
Journal: J Natl Cancer Inst Date: 2004-03-03 Impact factor: 13.506

7. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.

Authors: Carol L Shields; Abdallah Shelil; Jacqueline Cater; Anna T Meadows; Jerry A Shields
Journal: Arch Ophthalmol Date: 2003-11

8. Mutation and cancer: statistical study of retinoblastoma.

Authors: A G Knudson
Journal: Proc Natl Acad Sci U S A Date: 1971-04 Impact factor: 11.205

Review 9. Secondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor?

Authors: Dan S Gombos; John Hungerford; David H Abramson; Judith Kingston; Guillermo Chantada; Ira J Dunkel; Celia B G Antoneli; Mark Greenwald; Barret G Haik; Carlos A Leal; Aurora Medina-Sanson; Amy C Schefler; Gavivann Veerakul; Regina Wieland; Norbert Bornfeld; Mathew W Wilson; Christopher Bing On Yu
Journal: Ophthalmology Date: 2007-07 Impact factor: 12.079